Ultralife (ULBI) Cost of Revenue (2010 - 2026)

Ultralife has reported Cost of Revenue for 17 years, with the latest figure at $37.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 1.75% year-over-year to $37.3 million; the trailing twelve-month figure through Mar 2026 stood at $144.5 million (up 49.63% YoY), and the FY2025 full-year result was $145.1 million, up 18.83% from the prior year.
• Cost of Revenue for Q1 2026 stood at $37.3 million, up from $36.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $38.0 million in Q1 2025, with the low at $120000.0 in Q4 2024.
• Average Cost of Revenue over 5 years is $29.0 million, with a median of $30.5 million recorded in 2024.
• Year-over-year, Cost of Revenue tumbled 99.64% in 2024 and jumped 30254.17% in 2025.
• Tracing ULBI's Cost of Revenue over 5 years: stood at $28.0 million in 2022, then gained by 18.27% to $33.1 million in 2023, then plunged by 99.64% to $120000.0 in 2024, then jumped by 30254.17% to $36.4 million in 2025, then advanced by 2.5% to $37.3 million in 2026.
• The last three Cost of Revenue figures came in at $37.3 million (Q1 2026), $36.4 million (Q4 2025), and $33.8 million (Q3 2025), per Business Quant data.

Peer Comparison